LAENKYN
Live / Registered — Registered (as of 06 Jul 2021)
What this means for you
Registered since 06 Jul 2021. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use is due by 06 Jul 2027, and its filing window is open now).
Record
- Serial number
- 88894697
- Registration number
- 6406622
- Mark type
- Word mark
- Filed
- 30 Apr 2020
- Published for opposition
- 15 Sept 2020
- Registered
- 06 Jul 2021
- Next maintenance filing
- §8 declaration of use, due by 06 Jul 2027 (grace period to 06 Jan 2028)
- Attorney of record
- Phillip Barengolts
Goods and services
- Class 005 — Pharmaceuticals: Anti-infectives; Hormonal preparations; Pharmaceutical preparations for the treatment of renal diseases, cardiovascular diseases, liver diseases, pulmonary diseases, metabolic diseases, hematologic diseases, central nervous system diseases, vascular diseases, diabetes, cancer and fibrosis
Owner
- Bayer Aktiengesellschaft, 51373 Leverkusen, DE
- Bayer Aktiengesellschaft, 51373 Leverkusen, DE
- Bayer Aktiengesellschaft, 51373 Leverkusen, DE
Prosecution history
- 06 Jul 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 17 Dec 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 17 Dec 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 17 Dec 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 06 Jul 2021 — REGISTERED-PRINCIPAL REGISTER
- 02 Jun 2021 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 22 Apr 2021 — NOTICE OF ALLOWANCE CANCELLED
- 27 May 2021 — ASSIGNED TO PETITION STAFF
- 26 May 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 Apr 2021 — TEAS DELETE 1(B) BASIS RECEIVED
- 10 Nov 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 15 Sept 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Sept 2020 — PUBLISHED FOR OPPOSITION
- 26 Aug 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Aug 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER